Psychiatry and Neurology, Neurology · Las Vegas, NV
NPI
1730159385
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
7575 W Washington Ave, Suite 127-160
Las Vegas, NV, 89128
Phone (702) 505-4230
Groups this clinician bills Medicare through
Medicare paid, 2024
$207K
2,993 services
Medicare patients, 2024
276
Average age 74
Drug cost, 2024
$7.4M
1,401 prescriptions
Company payments, 2025
$457
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jonathan H McKinnon was code 95886 (electrical nerve conductivity), 438 times for 132 patients. In total Jonathan H McKinnon billed 2,993 services in 31 codes, and Medicare paid $207K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95886 Electrical Nerve Conductivity | Office | 438 | 132 | $66.22 | $29K |
| 99214 Office E&M - Established | Office | 429 | 219 | $81.43 | $35K |
| 95913 Electrical Nerve Conductivity | Office | 220 | 132 | $192.16 | $42K |
| 99215 Office E&M - Established | Office | 128 | 82 | $118.25 | $15K |
| 99205 Office E&M - New | Office | 71 | 71 | $140.61 | $9,983 |
| 95937 Electrical Nerve Conductivity | Office | 44 | 15 | $73.78 | $3,246 |
| 95812 Neurologic | Office | 40 | 38 | $241.32 | $9,653 |
| 99204 Office E&M - New | Office | 36 | 36 | $108.50 | $3,906 |
By year: 2022 $3.5M for 71,360 services; 2023 $1.8M for 17,708 services; 2024 $207K for 2,993 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan H McKinnon prescribed most often to Medicare patients was Gabapentin, with 91 prescriptions and refills. In total Jonathan H McKinnon wrote 1,401 Medicare prescriptions that cost $7.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 91 | 188 | 39 | $1,820 |
| Prednisone Generic | 84 | 183 | 24 | $1,228 |
| Donepezil Hcl Generic | 83 | 176 | 26 | $1,072 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 80 | 80 | Under 11 | $969K |
| Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 | 64 | 64 | Under 11 | $894K |
| Levetiracetam Generic | 64 | 181 | 18 | $1,594 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 63 | 149 | 19 | $1,490 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 62 | 62 | Under 11 | $703K |
| Ondansetron Odt Ondansetron | 47 | 47 | Under 11 | $154 |
| Radicava Ors Edaravone | 45 | 45 | Under 11 | $607K |
| Pyridostigmine Bromide Generic | 44 | 102 | 15 | $4,589 |
| Duloxetine Hcl Generic | 43 | 93 | 16 | $1,106 |
| Soliris Eculizumab | 40 | 40 | Under 11 | $1.9M |
| Mycophenolate Mofetil Generic | 38 | 58 | Under 11 | $1,646 |
| Riluzole Generic | 31 | 42 | Under 11 | $14K |
Brand drugs: 475 claims; generic drugs: 926 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jonathan H McKinnon $457 ($207 in general payments such as food, travel and fees and $250 for research) from 7 companies. The largest payer was Sarepta Therapeutics, Inc. with $250.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.